PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Hematology, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: ttogano@hosp.ncgm.go.jp.\', \'Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.\', \'AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan.\', \'AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.\', \'Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.\', \'Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.\', \'Department of Cardiology, National Center for Global Health and Medicine, Tokyo, Japan.\', \'Department of Hematology, National Center for Global Health and Medicine, Tokyo, Japan.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1341-321X(21)00204-X10.1016/j.jiac.2021.07.016
?:doi
?:hasPublicationType
?:journal
  • Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
is ?:pmid of
?:pmid
?:pmid
  • 34340930
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • The influence of pre-admission antiplatelet and anticoagulation therapy on the illness severity in hospitalized patients with COVID-19 in Japan.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all